S&P 500   4,274.99 (+0.03%)
DOW   33,565.28 (-0.16%)
QQQ   355.14 (+0.26%)
AAPL   170.48 (-0.86%)
MSFT   313.04 (+0.29%)
META   294.65 (-1.44%)
GOOGL   130.31 (+1.35%)
AMZN   126.14 (+0.13%)
TSLA   239.97 (-1.70%)
NVDA   424.19 (+1.21%)
NIO   8.49 (+0.95%)
BABA   86.02 (+0.13%)
AMD   98.37 (+2.51%)
T   14.89 (-0.87%)
F   12.38 (-0.40%)
MU   67.93 (-0.01%)
CGC   0.91 (-1.33%)
GE   111.03 (+1.00%)
DIS   79.84 (-0.26%)
AMC   7.62 (-3.67%)
PFE   32.24 (-0.49%)
PYPL   57.37 (-2.65%)
NFLX   379.29 (+0.01%)
S&P 500   4,274.99 (+0.03%)
DOW   33,565.28 (-0.16%)
QQQ   355.14 (+0.26%)
AAPL   170.48 (-0.86%)
MSFT   313.04 (+0.29%)
META   294.65 (-1.44%)
GOOGL   130.31 (+1.35%)
AMZN   126.14 (+0.13%)
TSLA   239.97 (-1.70%)
NVDA   424.19 (+1.21%)
NIO   8.49 (+0.95%)
BABA   86.02 (+0.13%)
AMD   98.37 (+2.51%)
T   14.89 (-0.87%)
F   12.38 (-0.40%)
MU   67.93 (-0.01%)
CGC   0.91 (-1.33%)
GE   111.03 (+1.00%)
DIS   79.84 (-0.26%)
AMC   7.62 (-3.67%)
PFE   32.24 (-0.49%)
PYPL   57.37 (-2.65%)
NFLX   379.29 (+0.01%)
S&P 500   4,274.99 (+0.03%)
DOW   33,565.28 (-0.16%)
QQQ   355.14 (+0.26%)
AAPL   170.48 (-0.86%)
MSFT   313.04 (+0.29%)
META   294.65 (-1.44%)
GOOGL   130.31 (+1.35%)
AMZN   126.14 (+0.13%)
TSLA   239.97 (-1.70%)
NVDA   424.19 (+1.21%)
NIO   8.49 (+0.95%)
BABA   86.02 (+0.13%)
AMD   98.37 (+2.51%)
T   14.89 (-0.87%)
F   12.38 (-0.40%)
MU   67.93 (-0.01%)
CGC   0.91 (-1.33%)
GE   111.03 (+1.00%)
DIS   79.84 (-0.26%)
AMC   7.62 (-3.67%)
PFE   32.24 (-0.49%)
PYPL   57.37 (-2.65%)
NFLX   379.29 (+0.01%)
S&P 500   4,274.99 (+0.03%)
DOW   33,565.28 (-0.16%)
QQQ   355.14 (+0.26%)
AAPL   170.48 (-0.86%)
MSFT   313.04 (+0.29%)
META   294.65 (-1.44%)
GOOGL   130.31 (+1.35%)
AMZN   126.14 (+0.13%)
TSLA   239.97 (-1.70%)
NVDA   424.19 (+1.21%)
NIO   8.49 (+0.95%)
BABA   86.02 (+0.13%)
AMD   98.37 (+2.51%)
T   14.89 (-0.87%)
F   12.38 (-0.40%)
MU   67.93 (-0.01%)
CGC   0.91 (-1.33%)
GE   111.03 (+1.00%)
DIS   79.84 (-0.26%)
AMC   7.62 (-3.67%)
PFE   32.24 (-0.49%)
PYPL   57.37 (-2.65%)
NFLX   379.29 (+0.01%)
NASDAQ:SNCE

Science 37 (SNCE) Stock Forecast, Price & News

$0.40
+0.00 (+1.08%)
(As of 02:44 PM ET)
Compare
Today's Range
$0.39
$0.41
50-Day Range
$0.22
$0.59
52-Week Range
$0.19
$1.99
Volume
142,116 shs
Average Volume
939,253 shs
Market Capitalization
$47.35 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.33

Science 37 MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
493.9% Upside
$2.33 Price Target
Short Interest
Healthy
1.41% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.18mentions of Science 37 in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.23 out of 5 stars

Medical Sector

369th out of 963 stocks

Commercial Physical Research Industry

7th out of 14 stocks


SNCE stock logo

About Science 37 (NASDAQ:SNCE) Stock

Science 37 Holdings, Inc. engages in patient-centric clinical trial activities in North Carolina. Its platform enables modern and digital approaches to clinical research, including the patient and trial investigators, nurses, coordinators, and sponsors, standardize evidence generation, and harmonize data. The company's platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating clinical trials; and extensive configuration to support virtually any phase of clinical study and therapeutic area. In addition, the company licenses its proprietary hosted technology platform to various life science institutions. It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina.

SNCE Price History

SNCE Stock News Headlines

The "Plug and Play" Model Putting Online Giants to Shame
While e-commerce has been undergoing a turbulent time, a "simple" model has grown 4X faster than Amazon over the last 3 years. Applying this model to high-margin, recession-resistant businesses has shown to be profitable. But that's just the beginning of explaining the 400+% growth - and potential - of this "diamond in the rough."
Science 37 Holdings, Inc. (NASDAQ:SNCE) Short Interest Update
Science 37 Holdings Inc.
The "Plug and Play" Model Putting Online Giants to Shame
While e-commerce has been undergoing a turbulent time, a "simple" model has grown 4X faster than Amazon over the last 3 years. Applying this model to high-margin, recession-resistant businesses has shown to be profitable. But that's just the beginning of explaining the 400+% growth - and potential - of this "diamond in the rough."
Science 37 Hldgs Earnings Preview
8-K: Science 37 Holdings, Inc.
See More Headlines
Receive SNCE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Science 37 and its competitors with MarketBeat's FREE daily newsletter.

SNCE Company Calendar

Last Earnings
8/08/2023
Today
9/27/2023
Next Earnings (Estimated)
11/09/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Commercial physical research
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SNCE
Fax
N/A
Employees
460
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$2.33
High Stock Price Forecast
$3.00
Low Stock Price Forecast
$1.00
Forecasted Upside/Downside
+483.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

Net Income
$-50,990,000.00
Net Margins
-217.87%
Pretax Margin
-218.01%

Debt

Sales & Book Value

Annual Sales
$70.15 million
Book Value
$0.83 per share

Miscellaneous

Free Float
108,563,000
Market Cap
$46.84 million
Optionable
Not Optionable
Beta
1.27
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for October 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. David Coman (Age 53)
    CEO & Director
    Comp: $796.13k
  • Ms. Christine A. Pellizzari J.D. (Age 55)
    Chief Legal & HR Officer and Sec.
    Comp: $521.58k
  • Ms. Darcy Forman (Age 47)
    Chief Delivery Officer
    Comp: $550.58k
  • Mr. Mike Zaranek (Age 52)
    Chief Financial Officer
  • Troy Bryenton
    Chief Technology Officer
  • Irena Lambridis
    VP and Head of Quality Assurance & Compliance
  • Ms. Margie Gimbel Kooman
    VP of Marketing & Communications
  • Mr. Drew Bustos
    Chief Strategy & Marketing Officer
  • Mr. Jonathan Cotliar M.D. (Age 51)
    Chief Medical Officer
  • Mr. Michael Shipton (Age 51)
    Chief Commercial Officer













SNCE Stock - Frequently Asked Questions

Should I buy or sell Science 37 stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Science 37 in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" SNCE shares.
View SNCE analyst ratings
or view top-rated stocks.

What is Science 37's stock price forecast for 2023?

4 analysts have issued 12-month price targets for Science 37's shares. Their SNCE share price forecasts range from $1.00 to $3.00. On average, they predict the company's stock price to reach $2.33 in the next year. This suggests a possible upside of 483.3% from the stock's current price.
View analysts price targets for SNCE
or view top-rated stocks among Wall Street analysts.

How have SNCE shares performed in 2023?

Science 37's stock was trading at $0.4152 at the beginning of the year. Since then, SNCE stock has decreased by 3.7% and is now trading at $0.40.
View the best growth stocks for 2023 here
.

When is Science 37's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 9th 2023.
View our SNCE earnings forecast
.

How were Science 37's earnings last quarter?

Science 37 Holdings, Inc. (NASDAQ:SNCE) released its quarterly earnings results on Tuesday, August, 8th. The company reported ($0.10) EPS for the quarter. The company had revenue of $15.35 million for the quarter, compared to analyst estimates of $11 million. Science 37 had a negative net margin of 217.87% and a negative trailing twelve-month return on equity of 77.11%.

What guidance has Science 37 issued on next quarter's earnings?

Science 37 issued an update on its FY 2023 earnings guidance on Tuesday, August, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $60.00 million-$60.00 million, compared to the consensus revenue estimate of $56.94 million.

What is Science 37's stock symbol?

Science 37 trades on the NASDAQ under the ticker symbol "SNCE."

Who are Science 37's major shareholders?

Science 37's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (0.58%), Renaissance Technologies LLC (0.55%), Kingswood Wealth Advisors LLC (0.55%), Geode Capital Management LLC (0.52%), Y Intercept Hong Kong Ltd (0.29%) and Goldman Sachs Group Inc. (0.28%).
View institutional ownership trends
.

How do I buy shares of Science 37?

Shares of SNCE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Science 37's stock price today?

One share of SNCE stock can currently be purchased for approximately $0.40.

How much money does Science 37 make?

Science 37 (NASDAQ:SNCE) has a market capitalization of $46.84 million and generates $70.15 million in revenue each year. The company earns $-50,990,000.00 in net income (profit) each year or ($1.15) on an earnings per share basis.

How many employees does Science 37 have?

The company employs 460 workers across the globe.

How can I contact Science 37?

Science 37's mailing address is 250 W 55TH ST. #3401, NEW YORK NY, 10019. The official website for the company is www.lifesciacquisition.com. The company can be reached via phone at 984-377-3737 or via email at investment@lifesciacquisition.com.

This page (NASDAQ:SNCE) was last updated on 9/27/2023 by MarketBeat.com Staff

My Account -